| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.8M | +55.5% |
| Operating Income | -$1.8M | -44.4% |
| Pre-tax Income | -$1.8M | -44.4% |
| Income Tax | $0 | — |
| Net Income | -$1.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $895K | -71.1% |
| Current Assets | $1.5M | -54.1% |
| Total Assets | $1.5M | -54.1% |
| Current Liabilities | $114K | -5.3% |
| Stockholders' Equity | $1.4M | -55.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | -78.7% |
| Capital Expenditures | $3K | -30.8% |
| Investing Cash Flow | -$3K | +30.8% |
| Financing Cash Flow | $550K | +0.0% |
| Free Cash Flow | -$2.2M | -78.3% |
| EPS (Diluted) | -$0.54 | -74.2% |